The Discounted Cash Flow (DCF) valuation of Catalyst Pharmaceuticals Inc (CPRX) is 39.84 USD. With the latest stock price at 21.78 USD, the upside of Catalyst Pharmaceuticals Inc based on DCF is 82.9%.
Based on the latest price of 21.78 USD and our DCF valuation, Catalyst Pharmaceuticals Inc (CPRX) is a buy. buying CPRX stocks now will result in a potential gain of 82.9%.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 7.7% | 6.5% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 29.13 - 71.02 | 39.84 |
| Upside | 33.7% - 226.1% | 82.9% |